Form 4 for IRMD IRADIMED CORP
Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0000898432-21-000772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-09 | 2021-12-07+ | IRMD | HAWKINS JAMES B | Dir | S - Sale+OE | $47.11 | -19.3K | 21.5K | -47% | -$909.3K |
| D | 2021-12-09 | 2021-12-07 | IRMD | HAWKINS JAMES B | Dir | M - OptEx | — | +4,222 | 21.5K | +24% | — |
| DM | 2021-12-09 | 2021-12-07+ | IRMD | HAWKINS JAMES B | Dir | A - Grant | $1.48 | +19.3K | 36.0K | +116% | +$28.6K |
| DM | 2021-12-09 | 2021-12-07+ | IRMD | HAWKINS JAMES B | Dir | M - OptEx | $0.00 | -23.5K | 10.0K | -70% | $0 |
| D | 2021-12-09 | 2021-12-07 | IRMD | HAWKINS JAMES B | Dir | A - Grant | $0.00 | +2,071 | 2,071 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-07 | S | D | 18,743 | $47.07 | 17,268 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-12-07 | M | A | 4,222 | — | 21,490 | D | — | — | (F3) The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
| 3 | Common | Common Stock | 2021-12-08 | A | A | 559 | $1.48 | 22,049 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 4 | Common | Common Stock | 2021-12-08 | S | D | 559 | $48.50 | 21,490 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-07 | A | A | 18,743 | $1.48 | 36,011 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 6 | Derivative | Stock Options (Right to Buy) | 2021-12-08 | M | D | 559 | $0.00 | 9,441 | D | $1.48 · — to 2023-12-31 | 559 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 7 | Derivative | Restricted Stock Units | 2021-12-07 | M | D | 4,222 | $0.00 | 2,037 | D | — · — to — | 4,222 Common Stock | (F4) Restricted Stock Units convert to common stock on a one-for-one basis. (F3) The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
| 8 | Derivative | Restricted Stock Units | 2021-12-07 | A | A | 2,071 | $0.00 | 2,071 | D | — · — to — | 2,071 Common Stock | (F4) Restricted Stock Units convert to common stock on a one-for-one basis. (F5) The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
| 9 | Derivative | Stock Options (Right to Buy) | 2021-12-07 | M | D | 18,743 | $0.00 | 10,000 | D | $1.48 · — to 2023-12-31 | 18,743 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |